C Ciron, P Morice, J Rousse, P Roy, PJ Royer… - JCI insight, 2024 - ncbi.nlm.nih.gov
Heterologous polyclonal antibodies (pAb) were shown to possess oncolytic properties a
century ago with reported clinical responses. More recent preclinical models confirmed pAb …